Breaking

The Best Five Sectors, #25
Pullbacks & Reversals: Stocks Setting Up for Big Moves!
Is This Rally Sustainable? You Better Bet Your Bullish Sweet Dollar It Is!
Israeli strike on cafe near Gaza City port kills dozens, hospital official says
British monarchy will receive around $118 million in government funding, annual report shows
Mexican authorities discover 20 bodies, some decapitated, on Sinaloa highway
Turkish police arrest four cartoonists after image authorities say depicts the Prophet Mohammed sparks protests
Thailand’s prime minister suspended over leaked phone call with former strongman

Investing
Economy
Latest News
Stock
Search for:

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Ian Rodger Appointed Managing Director

Crypto Market Recap: Metaplanet Buys 1,005 Bitcoin, REX to Launch Solana Staking ETF

13 Uranium Companies Exploring Canada’s Athabasca Basin

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Please enter CoinGecko Free Api Key to get this plugin works.

Disclaimer: BigCapitalTrend.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 bigcapitaltrend.com | All Rights Reserved

Top

Investing
Economy
Latest News
Stock

Type above and press Enter to search. Press Esc to cancel.